Why we need easy access to all data from all clinical trials and how to accomplish it

by Gøtzsche Peter C
Published 2011-11-01

Readers as research detectives

by Gøtzsche Peter C
Published 2009-01-01

Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies

by Gøtzsche Peter C, Lundh Andreas
Published 2008-04-01

Are benefits and harms in mammography screening given equal attention in scientific articles? A cross-sectional study

by Gøtzsche Peter C, Klahn Anders, Jørgensen Karsten
Published 2007-05-01

Sponsors’ participation in conduct and reporting of industry trials: a descriptive study

by Lundh Andreas, Krogsbøll Lasse T, Gøtzsche Peter C
Published 2012-08-01

Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention

by Gøtzsche Peter C, Hróbjartsson Asbjørn, Krogsbøll Lasse
Published 2009-01-01

Dealing with substantial heterogeneity in Cochrane reviews. Cross-sectional study

by Gøtzsche Peter C, Moustgaard Rasmus, Schroll Jeppe B
Published 2011-02-01

Flaws in design, analysis and interpretation of Pfizer's antifungal trials of voriconazole and uncritical subsequent quotations

by Jørgensen Karsten J, Johansen Helle, Gøtzsche Peter C
Published 2006-01-01

Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents

by Gøtzsche Peter C, Johansen Helle K, Due Anne K
Published 2006-08-01

Overdiagnosis in organised mammography screening in Denmark. A comparative study

by Gøtzsche Peter C, Zahl Per-Henrik, Jørgensen Karsten J
Published 2009-12-01

Industry-supported meta-analyses compared with meta-analyses with non-profit or no support: Differences in methodological quality and conclusions

by Faurschou Annesofie, Tendal Britta, Maric Katja L, Jørgensen Anders W, Gøtzsche Peter C
Published 2008-09-01